glp-1 agonists and inflammation Anti-inflammatory role of glucagon-like peptide 1 receptor its clinical implications Bridging the gap between GLP1-receptor

10.1016/j.coph.2023.102355 [DOI] [PubMed] [Google Scholar] 7

Blood sugar control appears slightly better with tirzepatide in head-to-head trials, possibly due to GIPs robust insulin secretion effects

The phase 3 TRIUMPH-4 data confirmed: 12 mg retatrutide produced 23.7% weight loss, translating to an average of 60 pounds lost

Most commonly, this means insulin through multiple daily injections or an insulin pump, though some providers use metformin as an adjunct since its generally considered safe in pregnancy

Consequently, they are not suggested as an initial treatment for T2DM

The evidence reviewed clearly supports that treating these conditions isolated is less effective than a holistic approach that addresses both metabolic and mental health aspects